Castle Biosciences, Inc. (CSTL) stock analysis
CSTL · Castle Biosciences, Inc.
Latest recorded price: USD 32.75
Sector and industry: Healthcare · Diagnostics & Research
Fiscal 2025 figures: revenue growth 35.9%, free cash flow margin 8.2%, ROIC -16.6%. The model flags 1 risk signal for this company.
Similar companies in Healthcare
- Quest Diagnostics Incorporated Common Stock (DGX)
- Danaher Corporation Common Stock (DHR)
- Guardant Health, Inc. (GH)
- IDEXX Laboratories, Inc. - Common Stock (IDXX)
- Illumina, Inc. - Common Stock (ILMN)
- IQVIA Holdings, Inc. Common Stock (IQV)
- Labcorp Holdings Inc. Common Stock (LH)
- Medpace Holdings, Inc. - Common Stock (MEDP)